FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access ...

A Brazilian cross-sectional study shows that adult T-cell leukemia/lymphoma is associated with collapsed naive and central ...

An in vitro study combining human atrial cardiomyocytes, fibroblasts and intermittent tachypacing reproduced selected electrical, calcium-handling and fibrotic changes associated with atrial ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

The Ark season 3 finale airs tonight on Syfy, and a 2026 Nature Communications study validates its core science: mice cloned ...

Your cavity is deep, so let's remove the nerve. You need root canal treatment. When told this at a dental clinic, many people ...

Explore how melanin, genetics and light scattering shape human eye colour, why blue eyes have no blue pigment, and why white ...

Scientists have turned blood cells from an 80-year-old into neural stem cells with a molecular age of less than 20, ...

Positive opinion supports reducing Libtayo dosing frequency from every three weeks to every six weeks after first 12 weeks of treatment Optional reduction of infusion time for 350 mg dose to 15 to 30 ...

AstraZeneca advances its ambition to revolutionize cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...

The hope with CAR T cell therapies for autoimmune disease is that they can reset the immune system and induce deep remission. But recent trial pauses have renewed concerns about safety, patient ...

Reactivate now to get the information you were looking for! You will get digital access to reviews and ratings for over 8,500 products and services to help you make better choices for life’s big ...